Symptomatic Improvement Within 3 Days With Tofacitinib Induction Therapy in Patients With Ulcerative Colitis: Results From OCTAVE Induction 1 and 2

被引:0
作者
Hanauer, Stephen [1 ]
Panaccione, Remo [2 ]
Danese, Silvio [3 ]
Cheifetz, Adam [4 ,5 ,6 ]
Reinisch, Walter [7 ]
Higgins, Peter D. R. [8 ]
Woodworth, Deborah A. [9 ]
Zhang, Haiying [9 ]
Friedman, Gary S. [9 ]
Lawendy, Nervin [9 ]
Quirk, Daniel [9 ]
Nduaka, Chudy I. [9 ]
Su, Chinyu [9 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Humanitas Clin & Res Ctr, Rozzano, Lombardia, Italy
[4] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[5] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA
[6] Harvard Med Sch, Boston, MA USA
[7] Med Univ Vienna, Hamilton, ON, Canada
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Pfizer Inc, Collegeville, PA USA
关键词
D O I
10.14309/00000434-201710001-00609
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
609
引用
收藏
页码:S331 / S331
页数:1
相关论文
共 1 条
[1]   Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis [J].
Sandborn, William J. ;
Su, Chinyu ;
Sands, Bruce E. ;
D'Haens, Geert R. ;
Vermeire, Severine ;
Schreiber, Stefan ;
Danese, Silvio ;
Feagan, Brian G. ;
Reinisch, Walter ;
Niezychowski, Wojciech ;
Friedman, Gary ;
Lawendy, Nervin ;
Yu, Dahong ;
Woodworth, Deborah ;
Mukherjee, Arnab ;
Zhang, Haiying ;
Healey, Paul ;
Panes, Julian .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18) :1723-1736